UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

mTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis

Nature communications, 2017-01, Vol.8 (1), p.14208-11, Article 14208

2017

Volltextzugriff (PDF)

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50

Annals of oncology, 2020-03, Vol.31 (3), p.404-411

2020

Volltextzugriff (PDF)

Liver from Bone Marrow in Humans

Hepatology (Baltimore, Md.), 2000-07, Vol.32 (1), p.11-16

2000

Volltextzugriff (PDF)

Human Herpesvirus 8–Related Primary Effusion Lymphoma After Liver Transplantation

American journal of transplantation, 2015-10, Vol.15 (10), p.2762-2766

2015

Volltextzugriff (PDF)

Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells

Oncogene, 2003-04, Vol.22 (15), p.2334-2342

2003

Volltextzugriff (PDF)

Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma : A Distinctive Tumor Entity Previously Included among Renal Cell Carcinomas of Children and Adolescents

The American journal of pathology, 2001-07, Vol.159 (1), p.179-192

2001

Volltextzugriff (PDF)

Immunohistochemical evaluation of TMPRSS2-ERG gene fusion in adenosis of the prostate

Human pathology, 2013-09, Vol.44 (9), p.1895-1901

2013

Volltextzugriff (PDF)

P3.09-04 Assessment of PD-L1 Expression in Cytology Samples: An Anlaysis of 263 Consecutive NSCLC Biopsies

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S948-S948

2018

Volltextzugriff (PDF)

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

Annals of oncology, 2018-08, Vol.29 (8), p.1853-1860

2018

Volltextzugriff (PDF)

Molecular testing in stage I–III non-small cell lung cancer: Approaches and challenges

Lung cancer (Amsterdam, Netherlands), 2021-12, Vol.162, p.42-53

2021

Volltextzugriff (PDF)

Herpes Simplex Virus Hepatitis: Case Report and Review

Clinical infectious diseases, 1997-03, Vol.24 (3), p.334-338

1997

Volltextzugriff (PDF)

P2.02-045 PD-L1 Assessment in Cytology Samples

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2115-S2115

2017

Volltextzugriff (PDF)

Expression of thyroid transcription factor-1 and other markers in sclerosing hemangioma of the lung

Archives of pathology & laboratory medicine (1976), 2001-10, Vol.125 (10), p.1335-1339

2001

Volltextzugriff (PDF)

P2.02-044 Pulmonary Findings in 7 Autopsy Cases of Patients Treated with Immune Checkpoint Inhibitors

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2115-S2115

2017

Volltextzugriff (PDF)

LBA50 Analysis of pathological features and efficacy outcomes with neoadjuvant nivolumab (N) plus platinum-doublet chemotherapy (C) for resectable non-small cell lung cancer (NSCLC) in CheckMate 816

Annals of oncology, 2022-09, Vol.33, p.S1415-S1416

2022

Volltextzugriff (PDF)

Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method

The American journal of surgical pathology, 2012-12, Vol.36 (12), p.1874-1882

2012

Volltextzugriff (PDF)

EP02.04-007 Phase 2 Trial of Neoadjuvant KRASG12C Directed Therapy with Adagrasib (MRTX849) With or Without Nivolumab in Resectable NSCLC (Neo-KAN)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S235

2022

Volltextzugriff (PDF)

P1.01-007 ALK Testing Trends and Patterns Among Community Practices in the United States

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1894-S1894

2017

Volltextzugriff (PDF)

P1.01-008 Real-World Patient Characteristics, Testing and Treatment Patterns of ALK+ NSCLC

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1894-S1895

2017

Volltextzugriff (PDF)

Sparc Analysis in the Phase III MPACT Trial of NAB-Paclitaxel (Nab-P) Plus Gemcitabine (GEM) vs GEM Alone for Patients with Metastatic Pancreatic Cancer (PC)

Annals of oncology, 2014-06, Vol.25, p.ii106-ii106

2014

Volltextzugriff (PDF)

OA12.01 Genomic and Immune Cell Landscape of Response to Chemo-Immunotherapy in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S867-S868

2021

Volltextzugriff (PDF)

Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours

British journal of cancer, 2004-09, Vol.91 (6), p.1112-1118

2004

Volltextzugriff (PDF)

Global gene expression profiling of pleural mesotheliomas : Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (6), p.2970-2979

2006

Volltextzugriff (PDF)

Occurrence and Risk Factors for Acute Lung Injury (ALI) and Organizing Pneumonia (OP) after Lung Transplant

The Journal of heart and lung transplantation, 2019-04, Vol.38 (4), p.S56-S57

2019

Volltextzugriff (PDF)

Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids

The Lancet (British edition), 2004-09, Vol.364 (9440), p.1157-1166

2004

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(117)

Publikationsform

Sprache

Englisch
(128)
Ungarisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

mTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50

Liver from Bone Marrow in Humans

Human Herpesvirus 8–Related Primary Effusion Lymphoma After Liver Transplantation

Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells

Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma : A Distinctive Tumor Entity Previously Included among Renal Cell Carcinomas of Children and Adolescents

Immunohistochemical evaluation of TMPRSS2-ERG gene fusion in adenosis of the prostate

P3.09-04 Assessment of PD-L1 Expression in Cytology Samples: An Anlaysis of 263 Consecutive NSCLC Biopsies

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

Molecular testing in stage I–III non-small cell lung cancer: Approaches and challenges

Herpes Simplex Virus Hepatitis: Case Report and Review

P2.02-045 PD-L1 Assessment in Cytology Samples

Expression of thyroid transcription factor-1 and other markers in sclerosing hemangioma of the lung

P2.02-044 Pulmonary Findings in 7 Autopsy Cases of Patients Treated with Immune Checkpoint Inhibitors

LBA50 Analysis of pathological features and efficacy outcomes with neoadjuvant nivolumab (N) plus platinum-doublet chemotherapy (C) for resectable non-small cell lung cancer (NSCLC) in CheckMate 816

Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method

EP02.04-007 Phase 2 Trial of Neoadjuvant KRASG12C Directed Therapy with Adagrasib (MRTX849) With or Without Nivolumab in Resectable NSCLC (Neo-KAN)

P1.01-007 ALK Testing Trends and Patterns Among Community Practices in the United States

P1.01-008 Real-World Patient Characteristics, Testing and Treatment Patterns of ALK+ NSCLC

Sparc Analysis in the Phase III MPACT Trial of NAB-Paclitaxel (Nab-P) Plus Gemcitabine (GEM) vs GEM Alone for Patients with Metastatic Pancreatic Cancer (PC)

OA12.01 Genomic and Immune Cell Landscape of Response to Chemo-Immunotherapy in Malignant Pleural Mesothelioma

Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours

Global gene expression profiling of pleural mesotheliomas : Overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction

Occurrence and Risk Factors for Acute Lung Injury (ALI) and Organizing Pneumonia (OP) after Lung Transplant

Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids

Suchergebnisse filtern